Addex Therapeutics Ltd header image

Addex Therapeutics Ltd

ADXN

Equity

ISIN CH0029850754 / Valor 2985075

SIX Swiss Exchange (2024-09-16)
CHF 0.07-1.41%

Addex Therapeutics Ltd
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Addex Therapeutics Ltd is a clinical-stage pharmaceutical company specializing in the development and commercialization of novel orally available small molecule drugs called allosteric modulators for neurological disorders. The company's focus lies in advancing innovative treatments for conditions affecting the central nervous system, with the goal of addressing unmet medical needs in this therapeutic area. Through their research and development efforts, Addex Therapeutics aims to bring new and effective treatment options to patients suffering from neurological disorders.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

%1Y
-95.3%3Y
-95.3%5Y

Performance

123%1Y
108%3Y
93.0%5Y

Volatility

Market cap

15 M

Market cap (USD)

Daily traded volume (Shares)

553,280

Daily traded volume (Shares)

1 day high/low

0.0752 / 0.069

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
3.00
Daniela Gie
Germany, 19 Jun 2024
star star star star star
Hedge found is betting on that stock. (Steven Boyd's Armistice Capital ).

EQUITIES OF THE SAME SECTOR

ImmunityBio Inc
ImmunityBio Inc ImmunityBio Inc Valor: 110468647
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.51%USD 3.49
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%USD 26.19
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.78%USD 28.34
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc West Pharmaceutical Services Inc Valor: 112491
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.29%USD 296.78
Service Corporation International
Service Corporation International Service Corporation International Valor: 969683
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.56%USD 80.34
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.95%CHF 33.50
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.08%USD 11.26
UCB SA
UCB SA UCB SA Valor: 986410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.92%EUR 164.45
Embla Medical hf
Embla Medical hf Embla Medical hf Valor: 1060135
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.32%DKK 30.80
AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 982352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.74%GBP 120.16